1. Home
  2. Pharma & Healthcare
  3. Global and China Non-Invasive Cancer Diagnostics Market 2020 by Company, Type and Application, Forecast to 2025

Global and China Non-Invasive Cancer Diagnostics Market 2020 by Company, Type and Application, Forecast to 2025

Publication Month: Mar 2020 | No. of Pages: 97 Published By: Global Info Research
Single User License: US $ 3980
Corporate User License: US $ 7960

Market Overview
The global Non-Invasive Cancer Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.7% in the forecast period of 2020 to 2025 and will expected to reach USD 127940 million by 2025, from USD 110450 million in 2019.

The Non-Invasive Cancer Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Non-Invasive Cancer Diagnostics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for revenue by Type and Application. This analysis can help you expand your business by targeting qualified niche markets.

Breakdown by Type, Non-Invasive Cancer Diagnostics market has been segmented into CTCs, CTNAS, Exosomes, etc.

Breakdown by Application, Non-Invasive Cancer Diagnostics has been segmented into Blood, Urine, Saliva, etc.

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Non-Invasive Cancer Diagnostics market presented in the report. This section sheds light on the sales growth of different regional and country-level Non-Invasive Cancer Diagnostics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Non-Invasive Cancer Diagnostics market.

For China, this report analyses the China market by players, Type and Application, for the period 2015-2025.

Competitive Landscape and Non-Invasive Cancer Diagnostics Market Share Analysis
Non-Invasive Cancer Diagnostics competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, Non-Invasive Cancer Diagnostics revenue generated, market share, headquarters, SWOT analysis, product launch. For the period 2015-2020, this study provides the Non-Invasive Cancer Diagnostics revenue and market share for each player covered in this report.

The major players covered in Non-Invasive Cancer Diagnostics are: Gen-Probe Inc, A&G Pharmaceutical, Cancer, Genetics Inc, Digene Corporation, Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Inc, Precision Therapeutics, AVIVA Biosciences Corporation, BIOVIEW Inc, Affymetrix Inc, etc. Among other players domestic and global, Non-Invasive Cancer Diagnostics market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Market segment by players, this report covers
Gen-Probe Inc
A&G Pharmaceutical
Cancer, Genetics Inc
Digene Corporation
Laboratory Corporation of America Holdings (LabCorp)
Quest Diagnostics Inc
Precision Therapeutics
AVIVA Biosciences Corporation
BIOVIEW Inc
Affymetrix Inc

Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina)
MENA (Saudi Arabia, UAE, Turkey and South Africa)

Market segment by Type, covers:
CTCs
CTNAS
Exosomes

Market segment by Application, can be divided into
Blood
Urine
Saliva

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Non-Invasive Cancer Diagnostics
1.2 Classification of Non-Invasive Cancer Diagnostics by Type
1.2.1 Overview: Global Non-Invasive Cancer Diagnostics Revenue by Type: 2015 Versus 2019 Versus 2025
1.2.2 Global Non-Invasive Cancer Diagnostics Revenue Market Share by Type in 2019
1.2.3 CTCs
1.2.4 CTNAS
1.2.5 Exosomes
1.3 Global Non-Invasive Cancer Diagnostics Market by Application
1.3.1 Overview: Global Non-Invasive Cancer Diagnostics Revenue by Application: 2015 Versus 2019 Versus 2025
1.3.2 Blood
1.3.3 Urine
1.3.4 Saliva
1.4 Global Non-Invasive Cancer Diagnostics Market Size and Forecast (2015-2025)
1.5 Global Non-Invasive Cancer Diagnostics Market Size by Regions: 2015 VS 2019 VS 2025
1.6 Global Non-Invasive Cancer Diagnostics Market Size by Regions (2015-2020)
1.7 Global Non-Invasive Cancer Diagnostics Market Size and Forecast by Regions (2020-2025)
1.7.1 North America Non-Invasive Cancer Diagnostics Status and Prospect (2015-2025)
1.7.2 Europe Non-Invasive Cancer Diagnostics Status and Prospect (2015-2025)
1.7.3 Asia Non-Invasive Cancer Diagnostics Status and Prospect (2015-2025)
1.7.4 South America Non-Invasive Cancer Diagnostics Status and Prospect (2015-2025)
1.7.5 Middle East & Africa Non-Invasive Cancer Diagnostics Status and Prospect (2015-2025)

2 Company Profiles
2.1 Gen-Probe Inc
2.1.1 Gen-Probe Inc Details
2.1.2 Gen-Probe Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Gen-Probe Inc SWOT Analysis
2.1.4 Gen-Probe Inc Product and Services
2.1.5 Gen-Probe Inc Non-Invasive Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.2 A&G Pharmaceutical
2.2.1 A&G Pharmaceutical Details
2.2.2 A&G Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 A&G Pharmaceutical SWOT Analysis
2.2.4 A&G Pharmaceutical Product and Services
2.2.5 A&G Pharmaceutical Non-Invasive Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.3 Cancer, Genetics Inc
2.3.1 Cancer, Genetics Inc Details
2.3.2 Cancer, Genetics Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Cancer, Genetics Inc SWOT Analysis
2.3.4 Cancer, Genetics Inc Product and Services
2.3.5 Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.4 Digene Corporation
2.4.1 Digene Corporation Details
2.4.2 Digene Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Digene Corporation SWOT Analysis
2.4.4 Digene Corporation Product and Services
2.4.5 Digene Corporation Non-Invasive Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.5 Laboratory Corporation of America Holdings (LabCorp)
2.5.1 Laboratory Corporation of America Holdings (LabCorp) Details
2.5.2 Laboratory Corporation of America Holdings (LabCorp) Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Laboratory Corporation of America Holdings (LabCorp) SWOT Analysis
2.5.4 Laboratory Corporation of America Holdings (LabCorp) Product and Services
2.5.5 Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.6 Quest Diagnostics Inc
2.6.1 Quest Diagnostics Inc Details
2.6.2 Quest Diagnostics Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Quest Diagnostics Inc SWOT Analysis
2.6.4 Quest Diagnostics Inc Product and Services
2.6.5 Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.7 Precision Therapeutics
2.7.1 Precision Therapeutics Details
2.7.2 Precision Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Precision Therapeutics SWOT Analysis
2.7.4 Precision Therapeutics Product and Services
2.7.5 Precision Therapeutics Non-Invasive Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.8 AVIVA Biosciences Corporation
2.8.1 AVIVA Biosciences Corporation Details
2.8.2 AVIVA Biosciences Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 AVIVA Biosciences Corporation SWOT Analysis
2.8.4 AVIVA Biosciences Corporation Product and Services
2.8.5 AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.9 BIOVIEW Inc
2.9.1 BIOVIEW Inc Details
2.9.2 BIOVIEW Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 BIOVIEW Inc SWOT Analysis
2.9.4 BIOVIEW Inc Product and Services
2.9.5 BIOVIEW Inc Non-Invasive Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.10 Affymetrix Inc
2.10.1 Affymetrix Inc Details
2.10.2 Affymetrix Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Affymetrix Inc SWOT Analysis
2.10.4 Affymetrix Inc Product and Services
2.10.5 Affymetrix Inc Non-Invasive Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2019)

3 Market Competition, by Players
3.1 Global Non-Invasive Cancer Diagnostics Market Size by Players (2015-2020)
3.2 China Non-Invasive Cancer Diagnostics Market Size by Players (2015-2020)
3.3 Market Concentration Rate
3.3.1 Top 5 Non-Invasive Cancer Diagnostics Players Market Share
3.3.2 Top 10 Non-Invasive Cancer Diagnostics Players Market Share

4 North America Market Size and Forecast by Countries
4.1 North America Non-Invasive Cancer Diagnostics Market Size by Countries (2015-2020)
4.2 North America Non-Invasive Cancer Diagnostics Market Size and Forecast by Countries (2015-2026)
4.3 United States Non-Invasive Cancer Diagnostics Market Size and Forecast (2015-2025)
4.4 Canada Non-Invasive Cancer Diagnostics Market Size and Forecast (2015-2025)
4.5 Mexico Non-Invasive Cancer Diagnostics Market Size and Forecast (2015-2025)

5 Europe Market Size and Forecast by Countries
5.1 Europe Non-Invasive Cancer Diagnostics Market Size by Countries (2015-2020)
5.2 Europe Non-Invasive Cancer Diagnostics Market Size and Forecast by Countries (2015-2026)
5.3 Germany Non-Invasive Cancer Diagnostics Market Size and Forecast (2015-2025)
5.4 France Non-Invasive Cancer Diagnostics Market Size and Forecast (2015-2025)
5.5 UK Non-Invasive Cancer Diagnostics Market Size and Forecast (2015-2025)
5.6 Russia Non-Invasive Cancer Diagnostics Market Size and Forecast (2015-2025)
5.7 Italy Non-Invasive Cancer Diagnostics Market Size and Forecast (2015-2025)

6 Asia-Pacific Market Size and Forecast by Countries
6.1 Asia-Pacific Non-Invasive Cancer Diagnostics Market Size by Regions (2015-2020)
6.2 Asia-Pacific Non-Invasive Cancer Diagnostics Market Size and Forecast by Regions (2015-2026)
6.3 China Non-Invasive Cancer Diagnostics Market Size and Forecast (2015-2025)
6.4 Japan Non-Invasive Cancer Diagnostics Market Size and Forecast (2015-2025)
6.5 Korea Non-Invasive Cancer Diagnostics Market Size and Forecast (2015-2025)
6.6 India Non-Invasive Cancer Diagnostics Market Size and Forecast (2015-2025)
6.7 Southeast Asia Non-Invasive Cancer Diagnostics Market Size and Forecast (2015-2025)

7 South America Market Size and Forecast by Countries
7.1 South America Non-Invasive Cancer Diagnostics Market Size by Countries (2015-2020)
7.2 South America Non-Invasive Cancer Diagnostics Market Size and Forecast by Countries (2015-2026)
7.3 Brazil Non-Invasive Cancer Diagnostics Market Size and Forecast (2015-2025)
7.4 Argentina Non-Invasive Cancer Diagnostics Market Size and Forecast (2015-2025)

8 Middle East & Africa Market Size and Forecast by Countries
8.1 Middle East & Africa Non-Invasive Cancer Diagnostics Revenue by Regions (2015-2020)
8.2 Middle East & Africa Non-Invasive Cancer Diagnostics Market Size and Forecast by Countries (2015-2026)
8.3 Saudi Arabia Non-Invasive Cancer Diagnostics Market Size and Forecast (2015-2025)
8.4 UAE Non-Invasive Cancer Diagnostics Market Size and Forecast (2015-2025)
8.5 Egypt Non-Invasive Cancer Diagnostics Market Size and Forecast (2015-2025)
8.6 South Africa Non-Invasive Cancer Diagnostics Market Size and Forecast (2015-2025)

9 Market Size Segment by Type
9.1 Global Non-Invasive Cancer Diagnostics Market Size and Forecast by Type (2015-2025)
9.1.1 Global Non-Invasive Cancer Diagnostics Market Size by Type (2015-2020)
9.1.2 Global Non-Invasive Cancer Diagnostics Market Size Forecast by Type (2020-2025)
9.2 China Non-Invasive Cancer Diagnostics Market Size and Forecast by Type (2015-2025)
9.2.1 China Non-Invasive Cancer Diagnostics Market Size by Type (2015-2020)
9.2.2 China Non-Invasive Cancer Diagnostics Market Size Forecast by Type (2020-2025)

10 Market Size Segment by Application
10.1 Global Non-Invasive Cancer Diagnostics Market Size and Forecast by Application (2015-2025)
10.1.1 Global Non-Invasive Cancer Diagnostics Market Size by Application (2015-2020)
10.1.2 Global Non-Invasive Cancer Diagnostics Market Size Forecast by Application (2020-2025)
10.2 China Non-Invasive Cancer Diagnostics Market Size and Forecast by Application (2015-2025)
10.2.1 China Non-Invasive Cancer Diagnostics Market Size by Application (2015-2020)
10.2.2 China Non-Invasive Cancer Diagnostics Market Size Forecast by Application (2020-2025)

11 Research Findings and Conclusion

12 Appendix
12.1 Methodology
12.2 Data Source
12.3 Disclaimer
12.4 About US

Tables and Figures

List of Tables

Table 1. Global Non-Invasive Cancer Diagnostics Revenue (USD Million) by Type: 2015 Versus 2019 Versus 2025
Table 2. Breakdown of Non-Invasive Cancer Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Non-Invasive Cancer Diagnostics Revenue (USD Million) by Application: 2015 Versus 2019 Versus 2025
Table 4. Global Market Non-Invasive Cancer Diagnostics Market Size (USD Million) Comparison by Regions (2020-2025)
Table 5. Global Non-Invasive Cancer Diagnostics Revenue (USD Million) by Regions (2015-2020)
Table 6. Global Non-Invasive Cancer Diagnostics Revenue Share by Regions (2015-2020)
Table 7. Global Non-Invasive Cancer Diagnostics Revenue (USD Million) by Regions (2020-2025)
Table 8. Global Non-Invasive Cancer Diagnostics Revenue Market Share by Regions (2020-2025)
Table 9. Gen-Probe Inc Corporate Information, Location and Competitors
Table 10. Gen-Probe Inc Major Business
Table 11. Gen-Probe Inc Non-Invasive Cancer Diagnostics Total Revenue (USD Million) (2017-2018)
Table 12. Gen-Probe Inc SWOT Analysis
Table 13. Gen-Probe Inc Non-Invasive Cancer Diagnostics Product and Solutions
Table 14. Gen-Probe Inc Non-Invasive Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 15. A&G Pharmaceutical Corporate Information, Location and Competitors
Table 16. A&G Pharmaceutical Major Business
Table 17. A&G Pharmaceutical Non-Invasive Cancer Diagnostics Total Revenue (USD Million) (2018-2019)
Table 18. A&G Pharmaceutical SWOT Analysis
Table 19. A&G Pharmaceutical Non-Invasive Cancer Diagnostics Product and Solutions
Table 20. A&G Pharmaceutical Non-Invasive Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 21. Cancer, Genetics Inc Corporate Information, Location and Competitors
Table 22. Cancer, Genetics Inc Major Business
Table 23. Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Total Revenue (USD Million) (2017-2018)
Table 24. Cancer, Genetics Inc SWOT Analysis
Table 25. Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Product and Solutions
Table 26. Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 27. Digene Corporation Corporate Information, Location and Competitors
Table 28. Digene Corporation Major Business
Table 29. Digene Corporation Non-Invasive Cancer Diagnostics Total Revenue (USD Million) (2017-2018)
Table 30. Digene Corporation SWOT Analysis
Table 31. Digene Corporation Non-Invasive Cancer Diagnostics Product and Solutions
Table 32. Digene Corporation Non-Invasive Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 33. Laboratory Corporation of America Holdings (LabCorp) Corporate Information, Location and Competitors
Table 34. Laboratory Corporation of America Holdings (LabCorp) Major Business
Table 35. Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Total Revenue (USD Million) (2017-2018)
Table 36. Laboratory Corporation of America Holdings (LabCorp) SWOT Analysis
Table 37. Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Product and Solutions
Table 38. Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 39. Quest Diagnostics Inc Corporate Information, Location and Competitors
Table 40. Quest Diagnostics Inc Major Business
Table 41. Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Total Revenue (USD Million) (2017-2018)
Table 42. Quest Diagnostics Inc SWOT Analysis
Table 43. Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Product and Solutions
Table 44. Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 45. Precision Therapeutics Corporate Information, Location and Competitors
Table 46. Precision Therapeutics Major Business
Table 47. Precision Therapeutics Non-Invasive Cancer Diagnostics Total Revenue (USD Million) (2017-2018)
Table 48. Precision Therapeutics SWOT Analysis
Table 49. Precision Therapeutics Non-Invasive Cancer Diagnostics Product and Solutions
Table 50. Precision Therapeutics Non-Invasive Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 51. AVIVA Biosciences Corporation Corporate Information, Location and Competitors
Table 52. AVIVA Biosciences Corporation Major Business
Table 53. AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Total Revenue (USD Million) (2017-2018)
Table 54. AVIVA Biosciences Corporation SWOT Analysis
Table 55. AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Product and Solutions
Table 56. AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 57. BIOVIEW Inc Corporate Information, Location and Competitors
Table 58. BIOVIEW Inc Major Business
Table 59. BIOVIEW Inc Non-Invasive Cancer Diagnostics Total Revenue (USD Million) (2017-2018)
Table 60. BIOVIEW Inc SWOT Analysis
Table 61. BIOVIEW Inc Non-Invasive Cancer Diagnostics Product and Solutions
Table 62. BIOVIEW Inc Non-Invasive Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 63. Affymetrix Inc Corporate Information, Location and Competitors
Table 64. Affymetrix Inc Major Business
Table 65. Affymetrix Inc Non-Invasive Cancer Diagnostics Total Revenue (USD Million) (2017-2018)
Table 66. Affymetrix Inc SWOT Analysis
Table 67. Affymetrix Inc Non-Invasive Cancer Diagnostics Product and Solutions
Table 68. Affymetrix Inc Non-Invasive Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 69. Global Non-Invasive Cancer Diagnostics Revenue (USD Million) by Players (2015-2020)
Table 70. Global Non-Invasive Cancer Diagnostics Revenue Share by Players (2015-2020)
Table 71. Key Players Non-Invasive Cancer Diagnostics Revenue (USD Million) in China (2015-2020)
Table 72. Key Players Non-Invasive Cancer Diagnostics Revenue Share in China (2015-2020)
Table 73. North America Non-Invasive Cancer Diagnostics Revenue (USD Million) by Countries (2015-2020)
Table 74. North America Non-Invasive Cancer Diagnostics Revenue Market Share by Countries (2015-2020)
Table 75. North America Non-Invasive Cancer Diagnostics Revenue (USD Million) by Countries (2020-2026)
Table 76. North America Non-Invasive Cancer Diagnostics Revenue Market Share by Countries (2020-2026)
Table 77. Europe Non-Invasive Cancer Diagnostics Revenue (USD Million) by Countries (2015-2020)
Table 78. Europe Non-Invasive Cancer Diagnostics Revenue Market Share by Countries (2015-2020)
Table 79. Europe Non-Invasive Cancer Diagnostics Revenue (USD Million) by Countries (2020-2026)
Table 80. Europe Non-Invasive Cancer Diagnostics Revenue Market Share by Countries (2020-2026)
Table 81. Asia-Pacific Non-Invasive Cancer Diagnostics Revenue (USD Million) by Countries (2015-2020)
Table 82. Asia-Pacific Non-Invasive Cancer Diagnostics Revenue Market Share by Countries (2015-2020)
Table 83. Asia-Pacific Non-Invasive Cancer Diagnostics Revenue (USD Million) by Countries (2020-2026)
Table 84. Asia-Pacific Non-Invasive Cancer Diagnostics Revenue Market Share by Countries (2020-2026)
Table 85. South America Non-Invasive Cancer Diagnostics Revenue (USD Million) by Countries (2015-2020)
Table 86. South America Non-Invasive Cancer Diagnostics Revenue Market Share by Countries (2015-2020)
Table 87. South America Non-Invasive Cancer Diagnostics Revenue (USD Million) by Countries (2020-2026)
Table 88. South America Non-Invasive Cancer Diagnostics Revenue Market Share by Countries (2020-2026)
Table 89. Middle East & Africa Non-Invasive Cancer Diagnostics Revenue (USD Million) by Countries (2015-2020)
Table 90. Middle East & Africa Non-Invasive Cancer Diagnostics Revenue Market Share by Countries (2015-2020)
Table 91. Middle East & Africa Non-Invasive Cancer Diagnostics Revenue (USD Million) by Countries (2020-2026)
Table 92. Middle East & Africa Non-Invasive Cancer Diagnostics Revenue Market Share by Countries (2020-2026)
Table 93. Global Non-Invasive Cancer Diagnostics Revenue (USD Million) by Type (2015-2020)
Table 94. Global Non-Invasive Cancer Diagnostics Revenue Share by Type (2015-2020)
Table 95. Global Non-Invasive Cancer Diagnostics Revenue Forecast by Type (2020-2025)
Table 96. Global Non-Invasive Cancer Diagnostics Market Share Forecast by Type (2020-2025)
Table 97. China Non-Invasive Cancer Diagnostics Revenue (USD Million) by Type (2015-2020)
Table 98. China Non-Invasive Cancer Diagnostics Revenue Share by Type (2015-2020)
Table 99. China Non-Invasive Cancer Diagnostics Revenue Forecast by Type (2020-2025)
Table 100. China Non-Invasive Cancer Diagnostics Market Share Forecast by Type (2020-2025)
Table 101. Global Non-Invasive Cancer Diagnostics Revenue (USD Million) by Application (2015-2020)
Table 102. Global Non-Invasive Cancer Diagnostics Revenue Share by Application (2015-2020)
Table 103. Global Non-Invasive Cancer Diagnostics Revenue Forecast by Application (2020-2025)
Table 104. Global Non-Invasive Cancer Diagnostics Market Share Forecast by Application (2020-2025)
Table 105. China Non-Invasive Cancer Diagnostics Revenue (USD Million) by Application (2015-2020)
Table 106. China Non-Invasive Cancer Diagnostics Revenue Share by Application (2015-2020)
Table 107. China Non-Invasive Cancer Diagnostics Revenue Forecast by Application (2020-2025)
Table 108. China Non-Invasive Cancer Diagnostics Market Share Forecast by Application (2020-2025)
List of Figures
Figure 1. Non-Invasive Cancer Diagnostics Picture
Figure 2. Global Non-Invasive Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 3. Global Non-Invasive Cancer Diagnostics Revenue Market Share by Type in 2019
Figure 4. CTCs Picture
Figure 5. CTNAS Picture
Figure 6. Exosomes Picture
Figure 7. Non-Invasive Cancer Diagnostics Revenue Market Share by Application in 2019
Figure 8. Blood Picture
Figure 9. Urine Picture
Figure 10. Saliva Picture
Figure 11. Global Non-Invasive Cancer Diagnostics Revenue and Growth Rate (2015-2025) (USD Million)
Figure 12. Global Non-Invasive Cancer Diagnostics Market Size Share by Regions (2015-2025)
Figure 13. Global Non-Invasive Cancer Diagnostics Market Size Share by Regions in 2019
Figure 14. Global Non-Invasive Cancer Diagnostics Revenue Market Share by Regions (2020-2025)
Figure 15. North America Non-Invasive Cancer Diagnostics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 16. Europe Non-Invasive Cancer Diagnostics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 17. Asia-Pacific Non-Invasive Cancer Diagnostics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 18. South America Non-Invasive Cancer Diagnostics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 19. Middle East & Africa Non-Invasive Cancer Diagnostics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 20. Global Non-Invasive Cancer Diagnostics Revenue Share by Players in 2019
Figure 21. Global Top 5 Players Non-Invasive Cancer Diagnostics Revenue Market Share in 2019
Figure 22. Top 10 Players Non-Invasive Cancer Diagnostics Revenue Market Share in Global Market in 2019
Figure 23. Global Non-Invasive Cancer Diagnostics Market Size (USD Million) by Type (2015-2025)
Figure 24. Global Non-Invasive Cancer Diagnostics Market Size Share by Application (2015-2025)
Figure 25. North America Non-Invasive Cancer Diagnostics Market Size Share by Countries (2015-2025)
Figure 26. North America Non-Invasive Cancer Diagnostics Market Size Share by Countries in 2019
Figure 27. United States Non-Invasive Cancer Diagnostics Market Size (USD Million) and Forecast (2015-2025)
Figure 28. Canada Non-Invasive Cancer Diagnostics Market Size (USD Million) and Forecast (2015-2025)
Figure 29. Mexico Non-Invasive Cancer Diagnostics Market Size (USD Million) and Forecast (2015-2025)
Figure 30. Europe Non-Invasive Cancer Diagnostics Market Size Share by Countries (2015-2025)
Figure 31. Europe Non-Invasive Cancer Diagnostics Market Size Share by Countries in 2019
Figure 32. Germany Non-Invasive Cancer Diagnostics Market Size (USD Million) and Forecast (2015-2025)
Figure 33. France Non-Invasive Cancer Diagnostics Market Size (USD Million) and Forecast (2015-2025)
Figure 34. Russia Non-Invasive Cancer Diagnostics Market Size (USD Million) and Forecast (2015-2025)
Figure 35. Italy Non-Invasive Cancer Diagnostics Market Size (USD Million) and Forecast (2015-2025)
Figure 36. Spain Non-Invasive Cancer Diagnostics Market Size (USD Million) and Forecast (2015-2025)
Figure 37. UK Non-Invasive Cancer Diagnostics Market Size (USD Million) and Forecast (2015-2025)
Figure 38. Asia Non-Invasive Cancer Diagnostics Market Size Share by Countries (2015-2025)
Figure 39. Asia Non-Invasive Cancer Diagnostics Market Size Share by Countries in 2019
Figure 40. China Non-Invasive Cancer Diagnostics Market Size (USD Million) and Forecast (2015-2025)
Figure 41. Japan Non-Invasive Cancer Diagnostics Market Size (USD Million) and Forecast (2015-2025)
Figure 42. Korea Non-Invasive Cancer Diagnostics Market Size (USD Million) and Forecast (2015-2025)
Figure 43. India Non-Invasive Cancer Diagnostics Market Size (USD Million) and Forecast (2015-2025)
Figure 44. Southeast Asia Non-Invasive Cancer Diagnostics Market Size (USD Million) and Forecast (2015-2025)
Figure 45. South America Non-Invasive Cancer Diagnostics Market Size Share by Countries (2015-2025)
Figure 46. South America Non-Invasive Cancer Diagnostics Market Size Share by Countries in 2019
Figure 47. Brazil Non-Invasive Cancer Diagnostics Market Size (USD Million) and Forecast (2015-2025)
Figure 48. Argentina Non-Invasive Cancer Diagnostics Market Size (USD Million) and Forecast (2015-2025)
Figure 49. Middle East & Africa Non-Invasive Cancer Diagnostics Market Size Share by Countries (2015-2025)
Figure 50. Middle East & Africa Non-Invasive Cancer Diagnostics Market Size Share by Countries in 2019
Figure 51. Saudi Arabia Non-Invasive Cancer Diagnostics Market Size (USD Million) and Forecast (2015-2025)
Figure 52. UAE Non-Invasive Cancer Diagnostics Market Size (USD Million) and Forecast (2015-2025)
Figure 53. Egypt Non-Invasive Cancer Diagnostics Market Size (USD Million) and Forecast (2015-2025)
Figure 54. South Africa Non-Invasive Cancer Diagnostics Market Size (USD Million) and Forecast (2015-2025)
Figure 55. Global Non-Invasive Cancer Diagnostics Revenue Share by Type (2015-2020)
Figure 56. China Non-Invasive Cancer Diagnostics Revenue Share by Type (2015-2020)
Figure 57. Global Non-Invasive Cancer Diagnostics Revenue Share by Application (2015-2020)
Figure 58. China Non-Invasive Cancer Diagnostics Revenue Share by Application (2015-2020)




Companies Mentioned
Gen-Probe Inc
A&G Pharmaceutical
Cancer, Genetics Inc
Digene Corporation
Laboratory Corporation of America Holdings (LabCorp)
Quest Diagnostics Inc
Precision Therapeutics
AVIVA Biosciences Corporation
BIOVIEW Inc
Affymetrix Inc

Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets